<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38288123</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Case report: A case of Acute Macular Neuroretinopathy secondary to Influenza A virus during Long COVID.</ArticleTitle><Pagination><StartPage>1302504</StartPage><MedlinePgn>1302504</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1302504</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1302504</ELocationID><Abstract><AbstractText>Ocular abnormalities have been reported in association with viral infections, including Long COVID, a debilitating illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This report presents a case of a female patient diagnosed with Acute Macular Neuroretinopathy (AMN) following an Influenza A virus infection during Long COVID who experienced severe inflammation symptoms and ocular complications. We hypothesize that the rare occurrence of AMN in this patient could be associated with the immune storm secondary to the viral infection during Long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Zhang, Xia, Li, He and Xie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaqi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yihao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaodong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital, Guizhou University of Traditional Chinese Medicine, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Runxi</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eye School of Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xuejun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="Y">Influenza A virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080363" MajorTopicYN="Y">White Dot Syndromes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">microvascular endothelial dysfunction</Keyword><Keyword MajorTopicYN="N">neutrophil extracellular trap</Keyword><Keyword MajorTopicYN="N">retinal diseases</Keyword><Keyword MajorTopicYN="N">retinoic acid depletion syndrome</Keyword><Keyword MajorTopicYN="N">virus infection</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>30</Day><Hour>3</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38288123</ArticleId><ArticleId IdType="pmc">PMC10822910</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1302504</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bos PJM, Deutman AF. Acute macular neuroretinopathy. Am J Ophthalmol (1975) 80:573&#x2013;84. doi:&#xa0;10.1016/0002-9394(75)90387-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9394(75)90387-6</ArticleId><ArticleId IdType="pubmed">1180301</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhavsar KV, Lin S, Rahimy E, Joseph A, Freund KB, Sarraf D, et al. . Acute macular neuroretinopathy: A comprehensive review of the literature. Survey Ophthalmol (2016) 61:538&#x2013;65. doi:&#xa0;10.1016/j.survophthal.2016.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.survophthal.2016.03.003</ArticleId><ArticleId IdType="pubmed">26973287</ArticleId></ArticleIdList></Reference><Reference><Citation>Turbeville SD, Cowan LD, Gass JDM. Acute macular neuroretinopathy: a review of the literature. Surv Ophthalmol (2003) 48(1):1&#x2013;11. doi:&#xa0;10.1016/s0039-6257(02)00398-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0039-6257(02)00398-3</ArticleId><ArticleId IdType="pubmed">12559324</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med (2022) 28:583&#x2013;90. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine (2021) 38:101019. doi:&#xa0;10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Azar G, Bonnin S, Vasseur V, Faure C, Salviat F, Clermont CV, et al. . Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy? J Clin Med (2021) 10:5038. doi:&#xa0;10.3390/jcm10215038</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10215038</ArticleId><ArticleId IdType="pmc">PMC8585041</ArticleId><ArticleId IdType="pubmed">34768555</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol (2021) 12:698169. doi:&#xa0;10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth JU, Narayanan R, Goyal J, Goyal V. Retinal vein occlusion in COVID-19: A novel entity. Indian J Ophthalmol (2020) 68:2291&#x2013;3. doi:&#xa0;10.4103/ijo.IJO_2380_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijo.IJO_2380_20</ArticleId><ArticleId IdType="pmc">PMC7727974</ArticleId><ArticleId IdType="pubmed">32971697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA (2020) 324:782. doi:&#xa0;10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali MAM, Spinler SA. COVID-19 and thrombosis: From bench to bedside. Trends Cardiovasc Med (2021) 31:143&#x2013;60. doi:&#xa0;10.1016/j.tcm.2020.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2020.12.004</ArticleId><ArticleId IdType="pmc">PMC7836332</ArticleId><ArticleId IdType="pubmed">33338635</ArticleId></ArticleIdList></Reference><Reference><Citation>Meineke R, Rimmelzwaan G, Elbahesh H. Influenza virus infections and cellular kinases. Viruses (2019) 11:171. doi:&#xa0;10.3390/v11020171</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11020171</ArticleId><ArticleId IdType="pmc">PMC6410056</ArticleId><ArticleId IdType="pubmed">30791550</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Sun Y, Wang Y, Yazici D, Azkur D, Ogulur I, et al. . Recent developments in the immunopathology of COVID -19. Allergy (2023) 78:369&#x2013;88. doi:&#xa0;10.1111/all.15593</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15593</ArticleId><ArticleId IdType="pmc">PMC10108124</ArticleId><ArticleId IdType="pubmed">36420736</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. Covid-19: Middle aged women face greater risk of debilitating long term symptoms. BMJ (2021) 372:n829. doi:&#xa0;10.1136/bmj.n829</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n829</ArticleId><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M, Artime A, Pariente E, Fierro P, Ruiz Y, Guti&#xe9;rrez S, et al. . Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study. Curr Med Res Opin (2022) 38:901&#x2013;9. doi:&#xa0;10.1080/03007995.2022.2042991</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/03007995.2022.2042991</ArticleId><ArticleId IdType="pmc">PMC8935459</ArticleId><ArticleId IdType="pubmed">35166141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Nakabo S, Blanco LP, O&#x2019;Neil LJ, Wigerblad G, Goel RR, et al. . Sex differences in neutrophil biology modulate response to type I interferons and immunometabolism. Proc Natl Acad Sci USA (2020) 117:16481&#x2013;91. doi:&#xa0;10.1073/pnas.2003603117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003603117</ArticleId><ArticleId IdType="pmc">PMC7368314</ArticleId><ArticleId IdType="pubmed">32601182</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Marriott I, Fish EN. Sex-based differences in immune function and responses to vaccination. Trans R Soc Trop Med Hygiene (2015) 109:9&#x2013;15. doi:&#xa0;10.1093/trstmh/tru167</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/tru167</ArticleId><ArticleId IdType="pmc">PMC4447843</ArticleId><ArticleId IdType="pubmed">25573105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejerina F, Catalan P, Rodriguez-Grande C, Adan J, Rodriguez-Gonzalez C, Mu&#xf1;oz P, et al. . Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect Dis (2022) 22:211. doi:&#xa0;10.1186/s12879-022-07153-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07153-4</ArticleId><ArticleId IdType="pmc">PMC8892394</ArticleId><ArticleId IdType="pubmed">35240997</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D, Lim JCT, Ferna&#xed;ndez SB, Joseph CR, Edwards SG, Neo ZW, et al. . Corrigendum: Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front Immunol (2022) 13:1036894. doi:&#xa0;10.3389/fimmu.2022.1036894</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1036894</ArticleId><ArticleId IdType="pmc">PMC9583834</ArticleId><ArticleId IdType="pubmed">36275692</ArticleId></ArticleIdList></Reference><Reference><Citation>Menuchin-Lasowski Y, Schreiber A, Lecanda A, Mecate-Zambrano A, Brunotte L, Psathaki OE, et al. . SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids. Stem Cell Rep (2022) 17:789&#x2013;803. doi:&#xa0;10.1016/j.stemcr.2022.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2022.02.015</ArticleId><ArticleId IdType="pmc">PMC8943915</ArticleId><ArticleId IdType="pubmed">35334213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, et al. . Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut (2022) 71:226&#x2013;9. doi:&#xa0;10.1136/gutjnl-2021-324280</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrao S, Gervasi F, Di Bernardo F, Natoli G, Raspanti M, Catalano N, et al. . Immunological characteristics of non-intensive care hospitalized COVID-19 patients: A preliminary report. JCM (2021) 10:849. doi:&#xa0;10.3390/jcm10040849</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040849</ArticleId><ArticleId IdType="pmc">PMC7921979</ArticleId><ArticleId IdType="pubmed">33669527</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol (2023) 21:133&#x2013;46. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. . Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; United States, March 2020&#x2013;November 2021. MMWR Morb Mortal Wkly Rep (2022) 71:713&#x2013;7. doi:&#xa0;10.15585/mmwr.mm7121e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;n-S&#xe1;nchez FJ, Mart&#xed;nez-Sell&#xe9;s M, Molero Garc&#xed;a JM, Moreno Guill&#xe9;n S, Rodr&#xed;guez-Artalejo F, Ruiz-Galiana J, et al. . Insights for COVID-19 in 2023. Rev Esp Quimioter (2023) 36:114&#x2013;24. doi:&#xa0;10.37201/req/122.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.37201/req/122.2022</ArticleId><ArticleId IdType="pmc">PMC10066911</ArticleId><ArticleId IdType="pubmed">36510683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. . Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behavior Immun (2022) 101:93&#x2013;135. doi:&#xa0;10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Osiaevi I, Schulze A, Evers G, Harmening K, Vink H, K&#xfc;mpers P, et al. . Persistent capillary rarefication in long COVID syndrome. Angiogenesis (2023) 26:53&#x2013;61. doi:&#xa0;10.1007/s10456-022-09850-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10456-022-09850-9</ArticleId><ArticleId IdType="pmc">PMC9366128</ArticleId><ArticleId IdType="pubmed">35951203</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med (2021) 27:601&#x2013;15. doi:&#xa0;10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al. . Post-acute COVID-19 syndrome. Eur Respir Rev (2022) 31:210185. doi:&#xa0;10.1183/16000617.0185-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, et al. . Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv [Preprint] (2022). doi:&#xa0;10.1101/2022.01.07.475453</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.07.475453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kub&#xe1;nkov&#xe1; M, Hohberger B, Hoffmanns J, F&#xfc;rst J, Herrmann M, Guck J, et al. . Physical phenotype of blood cells is altered in COVID-19. Biophys J (2021) 120:2838&#x2013;47. doi:&#xa0;10.1016/j.bpj.2021.05.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.05.025</ArticleId><ArticleId IdType="pmc">PMC8169220</ArticleId><ArticleId IdType="pubmed">34087216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sovann LY, Sar B, Kab V, Yann S, Kinzer M, Raftery P, et al. . (H3N2) virus outbreak in the Kingdom of Cambodia during the COVID-19 pandemic of 2020. Int J Infect Dis (2021) 103:352&#x2013;7. doi:&#xa0;10.1016/j.ijid.2020.11.178</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.11.178</ArticleId><ArticleId IdType="pmc">PMC10290288</ArticleId><ArticleId IdType="pubmed">33249287</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, et al. . Changes in influenza and other respiratory virus activity during the COVID-19 pandemic&#x2014;United States, 2020&#x2013;2021. Am J Transplant (2021) 21:3481&#x2013;6. doi:&#xa0;10.1111/ajt.16049</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16049</ArticleId><ArticleId IdType="pmc">PMC8653380</ArticleId><ArticleId IdType="pubmed">34624182</ArticleId></ArticleIdList></Reference><Reference><Citation>Conenello GM, Tisoncik JR, Rosenzweig E, Varga ZT, Palese P, Katze MG. A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo . J Virol (2011) 85:652&#x2013;62. doi:&#xa0;10.1128/JVI.01987-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01987-10</ArticleId><ArticleId IdType="pmc">PMC3020033</ArticleId><ArticleId IdType="pubmed">21084483</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, et al. . Tissue-specific immunopathology in fatal COVID-19. Am J Respir Crit Care Med (2021) 203:192&#x2013;201. doi:&#xa0;10.1164/rccm.202008-3265OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202008-3265OC</ArticleId><ArticleId IdType="pmc">PMC7874430</ArticleId><ArticleId IdType="pubmed">33217246</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzaglia G. Long COVID syndrome: lesson learned and future implications. JCM (2023) 12:3450. doi:&#xa0;10.3390/jcm12103450</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12103450</ArticleId><ArticleId IdType="pmc">PMC10219445</ArticleId><ArticleId IdType="pubmed">37240555</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo C, Jin Y, Zou S, Qi P, Xiao J, Tian H, et al. . Lethal influenza A virus preferentially activates TLR3 and triggers a severe inflammatory response. Virus Res (2018) 257:102&#x2013;12. doi:&#xa0;10.1016/j.virusres.2018.09.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2018.09.012</ArticleId><ArticleId IdType="pubmed">30248373</ArticleId></ArticleIdList></Reference><Reference><Citation>Righetto I, Gasparotto M, Casalino L, Vacca M, Filippini F. Exogenous players in mitochondria-related CNS disorders: viral pathogens and unbalanced microbiota in the gut-brain axis. Biomolecules (2023) 13:169. doi:&#xa0;10.3390/biom13010169</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13010169</ArticleId><ArticleId IdType="pmc">PMC9855674</ArticleId><ArticleId IdType="pubmed">36671555</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo XJ, Thomas PG. New fronts emerge in the influenza cytokine storm. Semin Immunopathol (2017) 39:541&#x2013;50. doi:&#xa0;10.1007/s00281-017-0636-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0636-y</ArticleId><ArticleId IdType="pmc">PMC5580809</ArticleId><ArticleId IdType="pubmed">28555383</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafqat A, Omer MH, Albalkhi I, Alabdul Razzak G, Abdulkader H, Abdul Rab S, et al. . Neutrophil extracellular traps and long COVID. Front Immunol (2023) 14:1254310. doi:&#xa0;10.3389/fimmu.2023.1254310</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1254310</ArticleId><ArticleId IdType="pmc">PMC10565006</ArticleId><ArticleId IdType="pubmed">37828990</ArticleId></ArticleIdList></Reference><Reference><Citation>Han L, Zhuang M, Deng J, Zheng Y, Zhang J, Nan M, et al. . SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5&#x2013;MAVS, TLR3&#x2013;TRIF, and cGAS&#x2013;STING signaling pathways. J Med Virol (2021) 93:5376&#x2013;89. doi:&#xa0;10.1002/jmv.27050</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27050</ArticleId><ArticleId IdType="pmc">PMC8242602</ArticleId><ArticleId IdType="pubmed">33913550</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter MM, Noel H, Brandt CR. The RLR intrinsic antiviral system is expressed in neural retina and restricts lentiviral transduction of human Mueller cells. Exp Eye Res (2023) 236:109647. doi:&#xa0;10.1016/j.exer.2023.109647</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.exer.2023.109647</ArticleId><ArticleId IdType="pmc">PMC10834037</ArticleId><ArticleId IdType="pubmed">37689341</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Jin T, Weng J. Endothelial cells as a key cell type for innate immunity: A focused review on RIG-I signaling pathway. Front Immunol (2022) 13:951614. doi:&#xa0;10.3389/fimmu.2022.951614</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.951614</ArticleId><ArticleId IdType="pmc">PMC9294349</ArticleId><ArticleId IdType="pubmed">35865527</ArticleId></ArticleIdList></Reference><Reference><Citation>Schustak J, Twarog M, Wu X, Wu HY, Huang Q, Bao Y. Mechanism of nucleic acid sensing in retinal pigment epithelium (RPE): RIG-I mediates type I interferon response in human RPE. J Immunol Res (2021) 2021:1&#x2013;14. doi:&#xa0;10.1155/2021/9975628</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9975628</ArticleId><ArticleId IdType="pmc">PMC8235977</ArticleId><ArticleId IdType="pubmed">34239945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashfaq I, Vrahimi M, Waugh S, Soomro T, Grinton ME, Browning AC. Acute macular neuroretinopathy associated with acute influenza virus infection. Ocular Immunol Inflammation (2021) 29:333&#x2013;9. doi:&#xa0;10.1080/09273948.2019.1681470</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2019.1681470</ArticleId><ArticleId IdType="pubmed">31697568</ArticleId></ArticleIdList></Reference><Reference><Citation>Michaelis M, Geiler J, Klassert D, Doerr HW, Cinatl J. Infection of human retinal pigment epithelial cells with influenza A viruses. Invest Ophthalmol Vis Sci (2009) 50:5419. doi:&#xa0;10.1167/iovs.09-3752</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.09-3752</ArticleId><ArticleId IdType="pubmed">19553611</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoser SL, Forster DJ, Rao NA. Systemic viral infections and their retinal and choroidal manifestations. Survey Ophthalmol (1993) 37:313&#x2013;52. doi:&#xa0;10.1016/0039-6257(93)90064-E</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0039-6257(93)90064-E</ArticleId><ArticleId IdType="pubmed">8387231</ArticleId></ArticleIdList></Reference><Reference><Citation>Galati D, Zanotta S, Capitelli L, Bocchino M. A bird&#x2019;s eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines. Allergy (2022) 77:100&#x2013;10. doi:&#xa0;10.1111/all.15004</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15004</ArticleId><ArticleId IdType="pmc">PMC8441836</ArticleId><ArticleId IdType="pubmed">34245591</ArticleId></ArticleIdList></Reference><Reference><Citation>Maggi E, Azzarone BG, Canonica GW, Moretta L. What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders. Allergy (2022) 77:1114&#x2013;28. doi:&#xa0;10.1111/all.15112</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15112</ArticleId><ArticleId IdType="pmc">PMC8652765</ArticleId><ArticleId IdType="pubmed">34582050</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing H, Wu X, Xiang M, Liu L, Novakovic VA, Shi J. Pathophysiological mechanisms of thrombosis in acute and long COVID-19. Front Immunol (2022) 13:992384. doi:&#xa0;10.3389/fimmu.2022.992384</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.992384</ArticleId><ArticleId IdType="pmc">PMC9709252</ArticleId><ArticleId IdType="pubmed">36466841</ArticleId></ArticleIdList></Reference><Reference><Citation>Jukema BN, Smit K, Hopman MTE, Bongers CCWG, Pelgrim TC, Rijk MH, et al. . Neutrophil and eosinophil responses remain abnormal for several months in primary care patients with COVID-19 disease. Front Allergy (2022) 3:942699. doi:&#xa0;10.3389/falgy.2022.942699</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/falgy.2022.942699</ArticleId><ArticleId IdType="pmc">PMC9365032</ArticleId><ArticleId IdType="pubmed">35966226</ArticleId></ArticleIdList></Reference><Reference><Citation>Aymonnier K, Ng J, Fredenburgh LE, Zambrano-Vera K, M&#xfc;nzer P, Gutch S, et al. . Inflammasome activation in neutrophils of patients with severe COVID-19. Blood Adv (2022) 6:2001&#x2013;13. doi:&#xa0;10.1182/bloodadvances.2021005949</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021005949</ArticleId><ArticleId IdType="pmc">PMC8741335</ArticleId><ArticleId IdType="pubmed">34991159</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisareva E, Badiou S, Mihalovi&#x10d;ov&#xe1; L, Mirandola A, Pastor B, Kudriavtsev A, et al. . Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients. J Med Virol (2023) 95:e28209. doi:&#xa0;10.1002/jmv.28209</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28209</ArticleId><ArticleId IdType="pmc">PMC9874393</ArticleId><ArticleId IdType="pubmed">36226380</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Wu Z, Long Q, Huang J, Hong T, Liu W, et al. . Insights into immunothrombosis: the interplay among neutrophil extracellular trap, von willebrand factor, and ADAMTS13. Front Immunol (2020) 11:610696. doi:&#xa0;10.3389/fimmu.2020.610696</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.610696</ArticleId><ArticleId IdType="pmc">PMC7738460</ArticleId><ArticleId IdType="pubmed">33343584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong F, You H, Zheng K, Tang R, Zheng C. The crosstalk between pattern-recognition receptor signaling and calcium signaling. Int J Biol Macromolecules (2021) 192:745&#x2013;56. doi:&#xa0;10.1016/j.ijbiomac.2021.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2021.10.014</ArticleId><ArticleId IdType="pubmed">34634335</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Ji Q, Cheng F, Chen D, Geng T, Huang Y, et al. . The lncRNAs involved in regulating the RIG-I signaling pathway. Front Cell Infect Microbiol (2022) 12:1041682. doi:&#xa0;10.3389/fcimb.2022.1041682</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1041682</ArticleId><ArticleId IdType="pmc">PMC9682092</ArticleId><ArticleId IdType="pubmed">36439216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Deng J, Han L, Zhuang M-W, Xu Y, Zhang J, et al. . SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Sig Transduct Target Ther (2022) 7:22. doi:&#xa0;10.1038/s41392-022-00878-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00878-3</ArticleId><ArticleId IdType="pmc">PMC8785035</ArticleId><ArticleId IdType="pubmed">35075101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Zhuang M-W, Han L, Zhang J, Nan M-L, Zhan P, et al. . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. Sig Transduct Target Ther (2020) 5:299. doi:&#xa0;10.1038/s41392-020-00438-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00438-7</ArticleId><ArticleId IdType="pmc">PMC7768267</ArticleId><ArticleId IdType="pubmed">33372174</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J, Zheng Y, Zheng S, Nan M, Han L, Zhang J, et al. . SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways. J Med Virol (2023) 95:e28561. doi:&#xa0;10.1002/jmv.28561</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28561</ArticleId><ArticleId IdType="pubmed">36755358</ArticleId></ArticleIdList></Reference><Reference><Citation>Udawatte DJ, Rothman AL. Viral suppression of RIPK1-mediated signaling. mBio (2021) 12:e01723&#x2013;21. doi:&#xa0;10.1128/mBio.01723-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01723-21</ArticleId><ArticleId IdType="pmc">PMC8406217</ArticleId><ArticleId IdType="pubmed">34372694</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, van der Ploeg K, Chakraborty S, Arunachalam PS, Mori DAM, Jacobson KB, et al. . Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study. Elife (2022) 11:e77943. doi: 10.7554/eLife.77943</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.77943</ArticleId><ArticleId IdType="pmc">PMC9566856</ArticleId><ArticleId IdType="pubmed">36239699</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow KT, Gale M, Loo Y-M. RIG-I and other RNA sensors in antiviral immunity. Annu Rev Immunol (2018) 36:667&#x2013;94. doi:&#xa0;10.1146/annurev-immunol-042617-053309</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-042617-053309</ArticleId><ArticleId IdType="pubmed">29677479</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarohan AR, K&#x131;z&#x131;l M, &#x130;nkaya A&#xc7;, Mahmud S, Akram M, Cen O. A novel hypothesis for COVID-19 pathogenesis: Retinol depletion and retinoid signaling disorder. Cell Signalling (2021) 87:110121. doi:&#xa0;10.1016/j.cellsig.2021.110121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2021.110121</ArticleId><ArticleId IdType="pmc">PMC8380544</ArticleId><ArticleId IdType="pubmed">34438017</ArticleId></ArticleIdList></Reference><Reference><Citation>Sir&#xe9;n J, Imaizumi T, Sarkar D, Pietil&#xe4; T, Noah DL, Lin R, et al. . Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines. Microbes Infection (2006) 8:2013&#x2013;20. doi:&#xa0;10.1016/j.micinf.2006.02.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2006.02.028</ArticleId><ArticleId IdType="pubmed">16797201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarohan AR. COVID-19: endogenous retinoic acid theory and retinoic acid depletion syndrome. Med Hypotheses (2020) 144:110250. doi:&#xa0;10.1016/j.mehy.2020.110250</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110250</ArticleId><ArticleId IdType="pmc">PMC7481114</ArticleId><ArticleId IdType="pubmed">33254555</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Xu X, Li J, Gu L, Yue Y, Sun F, et al. . RIG-I contributes to dsDNA-induced innate immune activation in human brain microvascular endothelial cells. Mol Immunol (2022) 152:78&#x2013;85. doi:&#xa0;10.1016/j.molimm.2022.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2022.10.009</ArticleId><ArticleId IdType="pubmed">36306644</ArticleId></ArticleIdList></Reference><Reference><Citation>Strzalkowski P, Steinberg JS, Dithmar S. COVID-19-assoziierte akute makul&#xe4;re Neuroretinopathie [COVID-19-associated acute macular neuroretinopathy]. Ophthalmologie (2023) 120(7):767&#x2013;70. doi:&#xa0;10.1007/s00347-022-01704-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00347-022-01704-5</ArticleId><ArticleId IdType="pmc">PMC9361229</ArticleId><ArticleId IdType="pubmed">35943530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed W, Suri A, Ahmed A. COVID-19 and Acute Macular Neuroretinopathy &#x2013; An underlying association? Ann Med Surg (Lond) (2022) 78:103847. doi:&#xa0;10.1016/j.amsu.2022.103847</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103847</ArticleId><ArticleId IdType="pmc">PMC9207085</ArticleId><ArticleId IdType="pubmed">35734676</ArticleId></ArticleIdList></Reference><Reference><Citation>David JA, Fivgas GD. Acute macular neuroretinopathy associated with COVID-19 infection. Am J Ophthalmol Case Rep (2021) 24:101232. doi:&#xa0;10.1016/j.ajoc.2021.101232</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajoc.2021.101232</ArticleId><ArticleId IdType="pmc">PMC8577875</ArticleId><ArticleId IdType="pubmed">34778601</ArticleId></ArticleIdList></Reference><Reference><Citation>
De Smet MD. Insights into the Physiopathology of Inflammatory Macular Edema, in: Developments in ophthalmology (2017). Available at: https://www.karger.com/Article/FullText/455279 (Accessed September 9, 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">28351051</ArticleId></ArticleIdList></Reference><Reference><Citation>Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, et al. . Mechanisms of macular edema: Beyond the surface. Prog Retinal Eye Res (2018) 63:20&#x2013;68. doi:&#xa0;10.1016/j.preteyeres.2017.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preteyeres.2017.10.006</ArticleId><ArticleId IdType="pubmed">29126927</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomel N, Shor R, Lippin N, Segal O, Greenbaum E, Schwartz S, et al. . COVID-19 pandemic lockdowns&#x2019; Impact on visual acuity of diabetic macular edema: A large cohort. Ophthalmologica (2023) 246:1&#x2013;8. doi:&#xa0;10.1159/000527942</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000527942</ArticleId><ArticleId IdType="pubmed">36380651</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltsev DS, Kulikov AN, Burnasheva MA, Chhablani J. Prevalence of resolved paracentral acute middle maculopathy lesions in fellow eyes of patients with unilateral retinal vein occlusion. Acta Ophthalmologica (2020) 98(1):e22&#x2013;8. doi:&#xa0;10.1111/aos.14196</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.14196</ArticleId><ArticleId IdType="pubmed">31347293</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnasheva MA, Maltsev DS, Kulikov AN, Sherbakova KA, Barsukov AV. Association of chronic paracentral acute middle maculopathy lesions with hypertension. Ophthalmol Retina (2020) 4:504&#x2013;9. doi:&#xa0;10.1016/j.oret.2019.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.oret.2019.12.001</ArticleId><ArticleId IdType="pubmed">31948908</ArticleId></ArticleIdList></Reference><Reference><Citation>Nencioni L, Sgarbanti R, Amatore D, Checconi P, Celestino I, Limongi D, et al. . Intracellular redox signaling as therapeutic target for novel antiviral strategy. CPD (2011) 17:3898&#x2013;904. doi:&#xa0;10.2174/138161211798357728</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161211798357728</ArticleId><ArticleId IdType="pubmed">21933147</ArticleId></ArticleIdList></Reference><Reference><Citation>Amatore D, Sgarbanti R, Aquilano K, Baldelli S, Limongi D, Civitelli L, et al. . Influenza virus replication in lung epithelial cells depends on redox-sensitive pathways activated by NOX4 -derived ROS . Cell Microbiol (2015) 17:131&#x2013;45. doi:&#xa0;10.1111/cmi.12343</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12343</ArticleId><ArticleId IdType="pmc">PMC4311438</ArticleId><ArticleId IdType="pubmed">25154738</ArticleId></ArticleIdList></Reference><Reference><Citation>Burggraaff MC, Trieu J, De Vries-Knoppert WAEJ, Balk L, Petzold A. The clinical spectrum of microcystic macular edema. Invest Ophthalmol Vis Sci (2014) 55:952. doi:&#xa0;10.1167/iovs.13-12912</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.13-12912</ArticleId><ArticleId IdType="pubmed">24398089</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>